Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain
AAM Supports Biden-Harris Administration’s 100-Day Review
Executive Summary
After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.